Media

 

Press Releases

  • Dec 05, 2017: LIVANOVA TO ACQUIRE IMTHERA MEDICAL INC
  • May 11, 2015: FIRST SUBJECTS IMPLANTED IN IMTHERA MEDICAL, INC. PIVOTAL STUDY
  • Nov 10, 2014: IMTHERA MEDICAL, INC. RECEIVES FDA APPROVAL FOR PIVOTAL STUDY FOR OBSTRUCTIVE SLEEP APNEA DEVICE
  • Sep 29, 2013: IMTHERA MEDICAL COMPLETES ENROLLMENT IN MULTI-CENTER STUDY OF THE AURA6000™ SYSTEM FOR OBSTRUCTIVE SLEEP APNEA

LONDON--Dec. 5, 2017 -- Company will enter obstructive sleep apnea space, enhancing its portfolio of Neuromodulation treatments and therapies. Read More.

San Diego, CA (May 11, 2015) - THN3 Study to Expand the Clinical Evidence for this Novel Neurostimulation Therapy for Moderate to Severe Obstructive Sleep Apnea. Read More.

San Diego, CA (Nov 10, 2014) - THN3 Study Will Expand the Clinical Evidence for this Novel Neurostimulation Therapy for Moderate to Severe Obstructive Sleep Apnea. Read More.

San Diego, CA (Sep 29, 2013) - THN2 Study Will Expand the Clinical Evidence for this Innovative Neurostimulation Therapy for Moderate to Severe Obstructive Sleep Apnea. Read More.

TV